Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Greenlight Cap. Re. (NQ: GLRE )

14.93 -0.07 (-0.47%)
Streaming Delayed Price Updated: 9:50 AM EST, Nov 22, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Headline News about Greenlight Cap. Re.

< Previous 1 2 Next >
GLRE Stock Earnings: Greenlight Capital Re Misses EPS for Q1 2024
GLRE stock results show that Greenlight Capital Re missed analyst estimates for earnings per share the first quarter of 2024. 
Via InvestorPlace
Author Lawrence McDonald Chats With "Motley Fool Money"
The topics include what an aging American population means for stocks and how natural gas companies benefit from a growing global middle class. 
Via The Motley Fool
Topics Energy
Exposures Fossil Fuels
GLRE Stock Earnings: Greenlight Capital Re Beats EPS for Q4 2023
GLRE stock results show that Greenlight Capital Re beat analyst estimates for earnings per share the fourth quarter of 2023. 
Via InvestorPlace
Insurance Stocks Moving In Friday's Intraday Session
Via Benzinga
Lemonade Stock Earns 87 RS Rating, Clears Cup Pattern Entry Point
A Relative Strength Rating upgrade for Lemonade shows improving technical performance. 
Via Investor's Business Daily
Greenlight Capital Re: Q3 Earnings Insights
Via Benzinga
Greenlight Capital Re's Earnings Outlook
Via Benzinga
Recap: Greenlight Capital Re Q1 Earnings
Via Benzinga
Earnings Scheduled For March 5, 2024
Companies Reporting Before The Bell • NIO (NYSE:NIO) is estimated to report quarterly loss at $0.51 per share on revenue of $2.29 billion. 
Via Benzinga
Greenlight Capital Re's Earnings: A Preview
Via Benzinga
Greenlight Capital Re Earnings Perspective: Return On Capital Employed
Via Benzinga
Preview: Greenlight Capital Re's Earnings
Via Benzinga
Insurance Stocks Moving In Tuesday's Intraday Session
Via Benzinga
Insurance Stocks Moving In Monday's Intraday Session
Via Benzinga
Insurance Stocks Moving In Tuesday's Intraday Session
Via Benzinga
Lemonade Stock Sees Relative Strength Rating Juice It Up
In a welcome move, insurance Lemonade stock saw its Relative Strength Rating improve from 64 to 74 on Friday. 
Via Investor's Business Daily
Progressive Stock Earns Membership In 95-Plus Composite Rating Club
Progressive saw an improvement in its IBD SmartSelect Composite Rating Tuesday, from 94 to 96. 
Via Investor's Business Daily
Major Hedge Fund Turns To Gold
Greenlight Capital reported a major increase in its exposure to gold as the hedge fund’s founder worries about the direction of the markets. 
Via Talk Markets
Insurance Stocks Moving In Friday's Intraday Session
Via Benzinga
Insurance Stocks Moving In Wednesday's Intraday Session
Via Benzinga
Insurance Stocks Moving In Thursday's Intraday Session
Via Benzinga
Renaissance Re Stock Mirrors Its Name; Profits, Sales Rebound
Renaissance Re stock gains have come on strong fundamentals including 60% profit growth last quarter, after 133% growth the prior quarter. 
Via Investor's Business Daily
Insurance Stocks Moving In Monday's Intraday Session
Via Benzinga
Insurance Stocks Moving In Tuesday's Intraday Session
Via Benzinga
Insurance Stocks Moving In Thursday's Intraday Session
Via Benzinga
What Is David Einhorn's Greenlight Capital Trading? A Look At Its Q1 Portfolio
Via Benzinga
Insurance Stocks Moving In Wednesday's Intraday Session
Via Benzinga
Insurance Stocks Moving In Wednesday's Intraday Session
Via Benzinga
Earnings Scheduled For March 8, 2023
Companies Reporting Before The Bell • Daktronics (NASDAQ:DAKT) is expected to report quarterly earnings at $0.00 per share on revenue of $164.68 million. 
Via Benzinga
Insurance Stocks Moving In Monday's Intraday Session
Via Benzinga
< Previous 1 2 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.